Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

[Systemic scleroderma].

Hunzelmann N.

Hautarzt. 2013 Apr;64(4):299-310; quiz 311-2. doi: 10.1007/s00105-013-2537-x. German.

PMID:
23576170
2.

[Systemic sclerosis].

Kleinert S, Tony HP, Kneitz C.

Internist (Berl). 2006 Oct;47(10):1051-61; quiz 1062. German.

PMID:
16972070
3.

[Systemic sclerosis--a challenge in rheumatology].

Saar P, Müller-Ladner U.

Z Rheumatol. 2006 Sep;65(5):429-38; quiz 439-40. German.

PMID:
16897099
4.

Assessing microvascular changes in systemic sclerosis diagnosis and management.

Cutolo M, Sulli A, Smith V.

Nat Rev Rheumatol. 2010 Oct;6(10):578-87. doi: 10.1038/nrrheum.2010.104. Epub 2010 Aug 10. Review.

PMID:
20703220
5.

Early systemic sclerosis-opportunities for treatment.

Sakkas LI, Simopoulou T, Katsiari C, Bogdanos D, Chikanza IC.

Clin Rheumatol. 2015 Aug;34(8):1327-31. doi: 10.1007/s10067-015-2902-5. Epub 2015 Feb 26. Review.

PMID:
25711876
6.

Vascular disease in systemic sclerosis.

Poredos P.

Vasa. 2011 Jan;40(1):3-4. No abstract available.

PMID:
21375075
7.

Systemic sclerosis/scleroderma: a treatable multisystem disease.

Hinchcliff M, Varga J.

Am Fam Physician. 2008 Oct 15;78(8):961-8.

8.

A 77-year-old woman with dyspnea and raynaud phenomenon.

Wang J, Sadoughi A, Dedopoulos S, Talwar A.

Chest. 2011 Apr;139(4):958-61. doi: 10.1378/chest.10-2405. No abstract available.

PMID:
21467065
9.

Graves' disease associated with primary systemic sclerosis.

Wimmersberger Y, Zuercher D.

Orbit. 2009;28(4):262-3.

PMID:
19839886
10.

Treatment of complications associated with systemic sclerosis.

Moore SC, Desantis ER.

Am J Health Syst Pharm. 2008 Feb 15;65(4):315-21. doi: 10.2146/ajhp070024. Review.

PMID:
18238768
11.

Management of cutaneous vascular complications in systemic scleroderma: experience from the German network.

Herrgott I, Riemekasten G, Hunzelmann N, Sunderkötter C.

Rheumatol Int. 2008 Aug;28(10):1023-9. doi: 10.1007/s00296-008-0556-1. Epub 2008 Mar 5.

PMID:
18320192
12.

Drug treatment of scleroderma.

Leighton C.

Drugs. 2001;61(3):419-27. Review.

PMID:
11293650
13.

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Co-Authors.

Ann Rheum Dis. 2009 May;68(5):620-8. doi: 10.1136/ard.2008.096677. Epub 2009 Jan 15.

PMID:
19147617
14.

Current treatment options in systemic Sclerosis (Scleroderma).

Stummvoll GH.

Acta Med Austriaca. 2002;29(1):14-9. Review.

PMID:
11899748
15.

Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.

Kumar U, Sankalp G, Sreenivas V, Kaur S, Misra D.

Rheumatol Int. 2013 Apr;33(4):1047-52. doi: 10.1007/s00296-012-2466-5. Epub 2012 Jul 26. Erratum in: Rheumatol Int. 2013 Apr;33(4):1053. Gokhle, Sankalp S [corrected to Sankalp, Gokhale].

PMID:
22833239
16.

Systemic sclerosis.

Ng SC.

Singapore Med J. 1992 Apr;33(2):189-92. Review.

PMID:
1621127
17.

[Strategy for early diagnosis of lung involvement in systemic scleroderma].

Diot E, Valat C, Boissinot E, Giraudeau B, Asquier E, Guilmot JL, Lemarié E, Diot P.

Rev Mal Respir. 2000 Dec;17(6):1073-80. Review. French.

PMID:
11217502
18.

Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients.

Giordano N, Montella A, Corallo C, Ruocco G, Chirico C, Palazzuoli A, Nuti R, Pecetti G.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S182-9. Epub 2015 Sep 1. Review.

PMID:
26339897
19.

[Systemic sclerosis].

Peltomaa R, Pettersson T, Tuompo R, Luosujärvi R.

Duodecim. 2013;129(19):1981-91. Review. Finnish.

PMID:
24218729
20.

Advances in the diagnosis and management of scleroderma-related vascular complications.

Kerin K, Yost JH.

Compr Ther. 1998 Nov-Dec;24(11-12):574-81. Review.

PMID:
9847974
Items per page

Supplemental Content

Write to the Help Desk